Data / Form D filings / Equon Pharmaceuticals, Inc.
Equon Pharmaceuticals, Inc.: Form D filing
Equon Pharmaceuticals, Inc., a biotechnology company in Henderson, NV, filed a Form D with the SEC in 2011. The latest, on August 26, 2011, reports an offering of $3.5 million with nothing sold yet.
Find out what Equon Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2764 N. GREEN VALLEY PARKWAY, SUITE 107, Henderson, NV, 89014
- Phone
- (858) 437-7333
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Year incorporated
- 2007
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 505
- SEC identifier (CIK)
- 1520581
The full lists. Form D filings in Nevada: 610 rows, $30.50, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 26, 2011 | New notice | $3,500,000 | $0 | $3,500,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeffrey Falk Taxson | Executive Officer, Director |
Other biotechnology companies in Nevada that filed recently
- Conexeu Sciences Inc. $4,801 · Nov 5, 2026
- Palimpsest Bio Corp. $172,000 · Oct 30, 2026
Every Form D from the week of Aug 22, 2011 · All recent filings in Nevada · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Equon Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.